Small-molecule anticancer agents kill cancer cells by harnessing reactive oxygen species in an iron-dependent manner

Area of Science:

• Medicinal Chemistry
• Cancer Biology
• Cell Death Mechanisms

Background:

• Epothilones are a class of anticancer agents.
• Current research focuses on novel small molecule anticancer agents.
• Understanding diverse cancer cell death mechanisms is crucial for developing new therapies.

Purpose of the Study:

• To discover novel small molecule anticancer agents.
• To investigate a new class of compounds with a unique mechanism of action.
• To explore the role of reactive oxygen species and iron in cancer cell death.

Main Methods:

• Synthesis of a library of open-chain epothilone analogs.
• Screening of compounds against selected cancer cell lines.
• Assays to measure reactive oxygen species production and iron dependency.
• Preliminary studies to assess the cell death pathway.

Main Results:

• A new class of small molecule anticancer agents was identified.
• These agents do not target tubulin.
• Cancer cell death is induced via an iron-dependent mechanism involving reactive oxygen species.
• Preliminary data suggest the involvement of ferroptosis.

Conclusions:

• A novel class of anticancer agents has been discovered with a unique mechanism of action.
• The compounds induce cancer cell death through iron-dependent reactive oxygen species generation.
• Ferroptosis is a likely mechanism of cell death, requiring further confirmation.
• Ongoing studies aim to validate ferroptosis and identify molecular targets.